Blood puncture site

PreclinicalBiologic

AAssistance Publique Hopitaux De Marseille

Blood puncture site is one of 61 biologic programs targeting Chronic Lymphocytic Leukemia. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Chronic Lymphocytic LeukemiaActive, not recruiting

Pre-TermCompleted

Obese PatientsRecruiting

Chronic Lymphocytic LeukemiaPreclinical

Active, not recruiting

Pre-TermPreclinical

Completed

Obese PatientsPreclinical

Recruiting

Competition

Competitive Landscape

94 competitors in Chronic Lymphocytic Leukemia

#DrugCompanyPhaseTrials

Venclexta

AbbVie

Phase 3

51 2

Gazyva

Roche

Phase 3

59 3

Fludara

Sanofi

Phase 3

38 4

Calquence

AstraZeneca

Phase 3

27 5

Revlimid

KKaruna Therapeutics, Inc., a Bristol Myers Squibb company

Phase 3

40 6

Brukinsa

BBeOne Medicines

Phase 3

17 7

Keytruda

Merck & Co.

Phase 3

2 8

Adcetris

Pfizer

Phase 3

1 9

Beqalzi

BBeOne Medicines

Phase 3

8 10

Campath

GGenzyme, a Sanofi Company

Phase 2

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Chronic Lymphocytic Leukemia1 trial

Evaluation of the Redox Profiles of Healthy and Pathological B Cells in Patients With Chronic Lymphocytic Leukemia

Unknown status·AAssistance Publique Hopitaux De Marseille··NCT03971565·47 enrolled

Obese Patients1 trial

Vitamin D and Its Metabolites Quantification in Adipose Tissues of Obese and Non-obese Patients.

Recruiting·AAssistance Publique Hopitaux De Marseille·N/A·NCT03008525·60 enrolled

T Cells1 trial

Immunophenotyping of Blast Cells and Immune Effector Cells in Peripheral Whole Blood and Bone Marrow Samples From AML and MDS Patients (AML)

Completed·AAssistance Publique Hopitaux De Marseille··NCT03801005·38 enrolled

Pre-Term1 trial

Effect of Site on Pain in Preterm Neonates

Completed·AAssistance Publique Hopitaux De Marseille·N/A·NCT02872415·81 enrolled

Sources

References

[1]
ClinicalTrials.gov — 4 trial records for Blood puncture site. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Blood puncture site compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Blood puncture site. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Assistance Publique Hopitaux De Marseille company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Highest Phase: Preclinical[1]
Company: AAssistance Publique Hopitaux De Marseille

Blood puncture site

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Chronic Lymphocytic Leukemia1 trial

Obese Patients1 trial

T Cells1 trial

Pre-Term1 trial

References

Drug Info

Quick Facts

Related News